Direxion Daily S&P Biotech Bear 3X ETF
LABD
18 hedge funds and large institutions have $16.6M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.
910% more call options, than puts
Call options by funds: $60.8M | Put options by funds: $6.02M
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
75% more capital invested
Capital invested by funds: $9.5M → $16.6M (+$7.12M)
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
19.65% less ownership
Funds ownership: 19.65% → 0% (-20%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.29M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.33M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.49M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.41M |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JF
Jump Financial
Chicago,
Illinois
|
-$1.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.23M |
| 3 |
VF
Virtu Financial
New York
|
-$588K |
| 4 |
GS
GTS Securities
Miami,
Florida
|
-$152K |
| 5 |
Jane Street
New York
|
-$130K |
LABD Hedge Fund Activity: Q3 2025 in Review
18 of the 7,642 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2025, worth a combined $16.6M — up 75% from $9.5M a quarter earlier.
Fund positioning in LABD was balanced in Q3 2025: 7 funds opened new positions, 7 closed out, 7 added to existing stakes and 4 trimmed.
The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $7.29M. The largest seller was Jump Financial, exiting entirely with an estimated $1.3M sold.
- 18 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $16.6M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2025, up 75% quarter-over-quarter.
- 7 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2025 and 7 closed out, a net change of 0 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2025 was BNP Paribas Financial Markets, an estimated $7.29M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2025 was Jump Financial, an estimated $1.3M sold.
Based on aggregated 13F filings for Q3 2025.